Akero Therapeutics Inc (AKRO)
19.72
+0.78
(+4.15%)
USD |
NASDAQ |
Apr 26, 16:00
19.72
0.00 (0.00%)
After-Hours: 17:31
Akero Therapeutics Total Liabilities (Quarterly): 44.96M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 44.96M |
| September 30, 2023 | 52.20M |
| June 30, 2023 | 47.37M |
| March 31, 2023 | 42.47M |
| December 31, 2022 | 30.01M |
| September 30, 2022 | 35.90M |
| June 30, 2022 | 37.30M |
| March 31, 2022 | 23.35M |
| December 31, 2021 | 26.44M |
| September 30, 2021 | 24.90M |
| June 30, 2021 | 17.88M |
| Date | Value |
|---|---|
| March 31, 2021 | 11.60M |
| December 31, 2020 | 14.63M |
| September 30, 2020 | 13.58M |
| June 30, 2020 | 10.40M |
| March 31, 2020 | 8.298M |
| December 31, 2019 | 9.392M |
| September 30, 2019 | 6.759M |
| June 30, 2019 | 4.779M |
| March 31, 2019 | 2.404M |
| December 31, 2018 | 127.07M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.779M
Minimum
Jun 2019
52.20M
Maximum
Sep 2023
24.33M
Average
23.35M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 235.21M |
| 89bio Inc | 59.96M |
| Viking Therapeutics Inc | 33.63M |
| Eli Lilly and Co | 53.14B |
| Ionis Pharmaceuticals Inc | 2.603B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 580.27M |
| Shareholders Equity (Quarterly) | 535.31M |